• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苹果和橘子?使用观察数据解释风险调整和工具变量估计的意向治疗效果。

Apples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational data.

机构信息

Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7573, USA.

出版信息

Am J Epidemiol. 2012 Jan 1;175(1):60-5. doi: 10.1093/aje/kwr283. Epub 2011 Nov 15.

DOI:10.1093/aje/kwr283
PMID:22085626
Abstract

Instrumental variable (IV) and risk adjustment (RA) estimators, including propensity score adjustments, are both used to alleviate confounding problems in nonexperimental studies on treatment effects, but it is not clear how estimates based on these 2 approaches compare. Methodological considerations have shown that IV and RA estimators yield estimates of distinct types of causal treatment effects regardless of confounding problems. Many investigators have neglected these distinctions. In this paper, the authors use 3 schematic models to explain visually the relations between IV and RA estimates of intended treatment effects as demonstrated in the methodological studies. When treatment effects are homogeneous across a study population or when treatment effects are heterogeneous across the study population but treatment decisions are unrelated to the treatment effects, RA and IV estimates should be equivalent when the respective assumptions are met. In contrast, when treatment effects are heterogeneous and treatment decisions are related to the treatment effects, RA estimates of treatment effect can asymptotically differ from IV estimates, but both are correct even when the respective assumptions are met. Appropriate interpretations of IV or RA estimates can be facilitated by developing conceptual models related to treatment choice and treatment effect heterogeneity prior to analyses.

摘要

工具变量(IV)和风险调整(RA)估计器,包括倾向评分调整,都被用于减轻治疗效果的非实验研究中的混杂问题,但尚不清楚这两种方法的估计值如何比较。方法学考虑表明,无论存在混杂问题,IV 和 RA 估计器都会产生不同类型的因果治疗效果的估计值。许多研究人员忽略了这些区别。在本文中,作者使用 3 个示意模型来说明在方法学研究中展示的 IV 和 RA 对预期治疗效果的估计值之间的关系。当治疗效果在研究人群中是同质的,或者当治疗效果在研究人群中是异质的,但治疗决策与治疗效果无关时,如果满足各自的假设,RA 和 IV 估计值应该是相等的。相比之下,当治疗效果是异质的,并且治疗决策与治疗效果相关时,RA 对治疗效果的估计值可能会从 IV 估计值中渐近地不同,但即使满足各自的假设,两者都是正确的。通过在分析之前开发与治疗选择和治疗效果异质性相关的概念模型,可以方便地对 IV 或 RA 估计值进行适当的解释。

相似文献

1
Apples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational data.苹果和橘子?使用观察数据解释风险调整和工具变量估计的意向治疗效果。
Am J Epidemiol. 2012 Jan 1;175(1):60-5. doi: 10.1093/aje/kwr283. Epub 2011 Nov 15.
2
Heterogeneity and the interpretation of treatment effect estimates from risk adjustment and instrumental variable methods.风险调整和工具变量方法中治疗效果估计值的异质性及解释
Med Care. 2007 Oct;45(10 Supl 2):S123-30. doi: 10.1097/MLR.0b013e318070c069.
3
Interpreting treatment-effect estimates with heterogeneity and choice: simulation model results.通过异质性和选择来解读治疗效果估计值:模拟模型结果
Clin Ther. 2009 Apr;31(4):902-19. doi: 10.1016/j.clinthera.2009.04.007.
4
Comparison of instrumental variable analysis using a new instrument with risk adjustment methods to reduce confounding by indication.新工具的工具变量分析与风险调整方法的比较,以减少指示性偏倚。
Am J Epidemiol. 2012 Jun 1;175(11):1142-51. doi: 10.1093/aje/kwr448. Epub 2012 Apr 17.
5
Methods to assess intended effects of drug treatment in observational studies are reviewed.本文综述了在观察性研究中评估药物治疗预期效果的方法。
J Clin Epidemiol. 2004 Dec;57(12):1223-31. doi: 10.1016/j.jclinepi.2004.03.011.
6
On causation in therapeutic research: observational studies, randomised experiments and instrumental variable analysis.论治疗研究中的因果关系:观察性研究、随机实验和工具变量分析。
Prev Med. 2011 Oct;53(4-5):239-41. doi: 10.1016/j.ypmed.2011.08.003. Epub 2011 Aug 12.
7
Heterogeneous treatment effects: what does a regression estimate?异质处理效应:回归估计了什么?
Eval Rev. 2010 Aug;34(4):334-61. doi: 10.1177/0193841X10372890.
8
Doubly robust estimators of causal exposure effects with missing data in the outcome, exposure or a confounder.在结局、暴露或混杂因素中存在缺失数据的情况下,因果暴露效应的双重稳健估计量。
Stat Med. 2012 Dec 30;31(30):4382-400. doi: 10.1002/sim.5643. Epub 2012 Oct 22.
9
[Meta-analysis of the Italian studies on short-term effects of air pollution].[意大利关于空气污染短期影响研究的荟萃分析]
Epidemiol Prev. 2001 Mar-Apr;25(2 Suppl):1-71.
10
Systematic differences in treatment effect estimates between propensity score methods and logistic regression.倾向得分法与逻辑回归在治疗效果估计上的系统差异。
Int J Epidemiol. 2008 Oct;37(5):1142-7. doi: 10.1093/ije/dyn079. Epub 2008 May 3.

引用本文的文献

1
Generating Practice-Based Evidence in the Use of Guideline-Recommended Combination Therapy for Secondary Prevention of Acute Myocardial Infarction.在使用指南推荐的联合治疗进行急性心肌梗死二级预防中生成基于实践的证据。
Pharmacy (Basel). 2022 Nov 3;10(6):147. doi: 10.3390/pharmacy10060147.
2
What are the health consequences associated with differences in medical malpractice liability laws? An instrumental variable analysis of surgery effects on health outcomes for proximal humeral facture across states with different liability rules.不同医疗事故责任法律相关的健康后果是什么?利用工具变量分析不同责任规则州的近端肱骨骨折手术效果对健康结果的影响。
BMC Health Serv Res. 2022 May 3;22(1):590. doi: 10.1186/s12913-022-07839-0.
3
Plant different, eat different? Insights from participatory agricultural research.
种植不同,饮食不同?参与式农业研究的启示。
PLoS One. 2022 Mar 25;17(3):e0265947. doi: 10.1371/journal.pone.0265947. eCollection 2022.
4
Association of Surgical Treatment With Adverse Events and Mortality Among Medicare Beneficiaries With Proximal Humerus Fracture.医疗保险受益人与肱骨近端骨折患者手术治疗与不良事件和死亡率的关系。
JAMA Netw Open. 2020 Jan 3;3(1):e1918663. doi: 10.1001/jamanetworkopen.2019.18663.
5
Re-examining the effect of door-to-balloon delay on STEMI outcomes in the context of unmeasured confounders: a retrospective cohort study.重新审视在未测量混杂因素的情况下门球时间对 STEMI 结局的影响:一项回顾性队列研究。
Sci Rep. 2019 Dec 27;9(1):19978. doi: 10.1038/s41598-019-56353-7.
6
Applying machine learning to predict real-world individual treatment effects: insights from a virtual patient cohort.应用机器学习预测真实世界的个体治疗效果:来自虚拟患者队列的见解。
J Am Med Inform Assoc. 2019 Oct 1;26(10):977-988. doi: 10.1093/jamia/ocz036.
7
Instrumental Variable Analyses in Pharmacoepidemiology: What Target Trials Do We Emulate?药物流行病学中的工具变量分析:我们应效仿哪些目标试验?
Curr Epidemiol Rep. 2017;4(4):281-287. doi: 10.1007/s40471-017-0120-1. Epub 2017 Oct 17.
8
Association between higher rates of cardioprotective drug use and survival in patients on dialysis.透析患者中使用心脏保护药物的较高比例与生存率之间的关联。
Res Social Adm Pharm. 2015 Nov-Dec;11(6):824-43. doi: 10.1016/j.sapharm.2014.12.007. Epub 2014 Dec 31.
9
Instrumental variable methods to assess quality of care the marginal effects of process-of-care on blood pressure change and treatment costs.用于评估医疗质量、护理过程对血压变化的边际效应以及治疗成本的工具变量方法。
Res Social Adm Pharm. 2015 Mar-Apr;11(2):e69-83. doi: 10.1016/j.sapharm.2014.07.007. Epub 2014 Aug 1.
10
Pancreatectomy predicts improved survival for pancreatic adenocarcinoma: results of an instrumental variable analysis.胰腺切除术可预测胰腺腺癌患者生存率的提高:工具变量分析结果
Ann Surg. 2015 Apr;261(4):740-5. doi: 10.1097/SLA.0000000000000796.